Fig. 5
From: Immune profiling of canine B cell lymphoma reveals cross-species conservation of prognostic markers

Circulating biomarker profiling for aggressive canine BCL in five dogs with exceptional responses and five dogs with poor responses to CHOP chemotherapy. (A) plasma VEGFA concentrations, (B) plasma IL-6 concentrations, and (C) neutrophil-to-lymphocyte ratio. Comparisons between two groups performed using two-tailed Mann-Whitney tests, p< *0.05, **0.01. Dotted lines represent limit of detection.